Sign In
Buy ANVS
$1.77
+0.0200 (+1.14%)
At Close: Jun 22, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS
12:33am, Wednesday, 04'th Aug 2021
NEW YORK, Aug. 4, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS). Such investors are advised to c
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Annovis Bio, Inc. (“Annovis” or the “Compan
The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
05:05pm, Tuesday, 03'rd Aug 2021
LOS ANGELES--(BUSINESS WIRE)---- $ANVS #investors--The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
Detours In The Golden Age Of Alzheimer's Drug Stock Investments
02:58pm, Tuesday, 03'rd Aug 2021
Biogen's Aduhelm performed no better than placebo in non-ApoE4 carriers and only slightly slowed down the progression of Alzheimer's disease in ApoE4 carriers.
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Annovis Bio, Inc.
10:47pm, Monday, 02'nd Aug 2021
NEW YORK--(BUSINESS WIRE)---- $ANVS--The law firm of Kirby McInerney LLP is investigating potential claims against Annovis Bio, Inc. (“Annovis” or the “Company”) (NYSE: ANVS). The investigatio
Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Annovis Bio, Inc. (ANVS) Common Stock
03:19pm, Monday, 02'nd Aug 2021
New York, New York--(Newsfile Corp. - August 2, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Annovis Bio, Inc. common stock (NYSE American: ANV
Former Biotech Penny Stocks Seeing Explosive Moves In 2021
10:53am, Monday, 02'nd Aug 2021
Are penny stocks worth it? Take a look at these 3 seeing explosive moves this year.
Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday
03:30pm, Thursday, 29'th Jul 2021
A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.
ANVS Stock: The Alzheimer's Drug News That Has Annovis Bio Plunging Today
01:33pm, Thursday, 29'th Jul 2021
Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug. The post ANVS Stock: The Alzheimer's Drug News That Has Annovis B
ANVS Stock Fell Over 57% Intraday: Why It Happened
10:43am, Thursday, 29'th Jul 2021
The stock price of Annovis Bio Inc (NYSEAMERICAN: ANVS) fell by over 57% during intraday trading. This is why it happened.
Annovis Bio Presents New Clinical and Biomarker Data at 2021 Alzheimer's Association International Conference
07:30pm, Wednesday, 28'th Jul 2021
Berwyn, Pennsylvania--(Newsfile Corp. - July 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD
Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks
07:37am, Saturday, 17'th Jul 2021
Treating Alzheimer's is extremely difficult, but these innovative companies are taking a stab at it.
Here's Why The Biotech Stocks You Bought Keep Going Down
05:37am, Saturday, 17'th Jul 2021
Good news! There's a way to avoid this portfolio pain -- and it doesn't involve avoiding the whole sector.
Better Biotech Stock: Biogen vs. Annovis Bio
07:38am, Friday, 16'th Jul 2021
Both are making Alzheimer's drugs, but only one can claim success as of today.
7 Top-Rated Pharmaceutical Companies to Invest In for July
09:15am, Friday, 09'th Jul 2021
Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest I
